{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:27:54Z","timestamp":1753892874309,"version":"3.41.2"},"reference-count":98,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Alzheimer\u2019s disease (AD) is frequently accompanied by behavioral and psychological symptoms of dementia (BPSD). Studies have shown that 3\u00d7Tg-AD mice, a classical animal model of AD, exhibit anxiety and depression-like behaviors characteristic of BPSD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>This study investigated the effects of Qifuyin on anxiety and depression-like behaviors in 3\u00d7Tg-AD mice.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The 20 male and female C57BL\/6 mice at 10.3 months of age were used as the control group, while the 82 male and female 3\u00d7Tg-AD mice of the same age were divided into five groups. The control and model groups were gavaged with solvent, the positive medicine group received a combination of donepezil and memantine, and the Qifuyin (QFY) groups were divided into three doses: low, medium, and high. The effects of QFY on anxiety-like behaviors in mice were assessed using the open field test (OFT) and elevated plus maze (EPM) test, while depression-like behaviors were evaluated through the forced swim test (FST) and sucrose splash test (ST). Plasma levels of corticosterone (CORT), testosterone (T), and estradiol (E2) were measured using ELISA, while adrenocorticotropic hormone (ACTH), follicle-stimulating hormone (FSH), luteinizing hormone (LH), corticotropin-releasing hormone (CRH), and gonadotropin-releasing hormone (GnRH) were quantified via radioimmunoassay. Differences in plasma hormone levels among groups were analyzed using principal component analysis (PCA). Pearson correlation analysis was conducted to explore the relationships between plasma hormones and behavioral phenotypes, and multiple linear regression was employed to identify the hormones most strongly correlated with anxiety and depression-like behaviors in mice following QFY treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In 3\u00d7Tg-AD mice, anxiety-like behaviors were characterized by reduced the duration, number of visits, and total distances in central area during the OFT. The EPM revealed reduced the duration and frequency in the open arms for both sexes. Depression-like behaviors were evident in the FST, with increased immobility, and in the ST, with prolonged grooming latency in both sexes and reduced grooming frequency in females. The treatment of QFY alleviated these behaviors. In males, In the model group, plasma ACTH, GnRH, and FSH levels were significantly decreased. In the QFY-treated group, plasma CRH levels were significantly reduced, while GnRH levels were significantly increased. In the model group of females, plasma ACTH levels were significantly elevated, while FSH and LH levels were markedly reduced. In the QFY-treated group, plasma CORT levels were significantly decreased, whereas FSH and LH levels were significantly increased. Multiple linear regression indicated QFY mainly mitigates anxiety and depression-like symptoms through modulating GnRH in males and T and ACTH in females.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The administration of QFY alleviates anxiety and depression in 3\u00d7Tg-AD mice by regulating the HPA, HPT and HPO axes.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpsyt.2025.1554866","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T05:40:23Z","timestamp":1747201223000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Qifuyin alleviates anxiety and depression in 3\u00d7Tg-AD mice by modulating neuroendocrine function"],"prefix":"10.3389","volume":"16","author":[{"given":"Tianhao","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junqi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shixue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaorui","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer\u2019s disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25245789","article-title":"Comprehensive review on alzheimer\u2019s disease: causes and treatment","volume":"25","author":"Breijyeh","year":"2020","journal-title":"Molecules"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24021059","article-title":"Alzheimer\u2019s disease-biochemical and psychological background for diagnosis and treatment","volume":"24","author":"Beata","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2012.00073","article-title":"Behavioral and psychological symptoms of dementia","volume":"3","author":"Cerejeira","year":"2012","journal-title":"Front Neurol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"h369","DOI":"10.1136\/bmj.h369","article-title":"Assessment and management of behavioral and psychological symptoms of dementia","volume":"350","author":"Kales","year":"2015","journal-title":"BMJ"},{"year":"2020","author":"Kumar","key":"B6"},{"key":"B7","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.neurobiolaging.2019.10.008","article-title":"Apathy and anxiety are early markers of Alzheimer\u2019s disease","volume":"85","author":"Johansson","year":"2020","journal-title":"Neurobiol Aging"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3233\/ADR-210294","article-title":"The relationship between anxiety and alzheimer\u2019s disease","volume":"5","author":"Mendez","year":"2021","journal-title":"J Alzheimers Dis Rep"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/00019442-200203000-00004","article-title":"Provisional diagnostic criteria for depression of Alzheimer disease: rationale and background","volume":"10","author":"Olin","year":"2002","journal-title":"Am J Geriatr Psychiatry"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1988.00520350020008","article-title":"Major depression in primary dementia","volume":"45","author":"Zubenko","year":"1988","journal-title":"Clin Neuropathol Correlates Arch Neurol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-191078","article-title":"Depression is associated with tau and not amyloid positron emission tomography in cognitively normal adults","volume":"74","author":"Babulal","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2021.774049","article-title":"Plasma total tau and neurobehavioral symptoms of cognitive decline in cognitively normal older adults","volume":"12","author":"Hall","year":"2021","journal-title":"Front Psychol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/gps.v36.1","article-title":"Alzheimer\u2019s disease biomarkers as predictors of trajectories of depression and apathy in cognitively normal individuals, mild cognitive impairment, and Alzheimer\u2019s disease dementia","volume":"36","author":"Banning","year":"2021","journal-title":"Int J Geriatr Psychiatry"},{"key":"B14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.biopsych.2022.01.012","article-title":"Development of apathy, anxiety, and depression in cognitively unimpaired older adults: effects of alzheimer\u2019s disease pathology and cognitive decline","volume":"92","author":"Johansson","year":"2022","journal-title":"Biol Psychiatry"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/gps.70080","article-title":"The Impact of Behavioral and Psychological Symptoms of Dementia on Mental Health, Sleep Quality, and Caregiver's Burden","volume":"40","author":"Chen","year":"2025","journal-title":"Int J Geriatr Psychiatry"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2017.17040442","article-title":"Longitudinal association of amyloid beta and anxious-depressive symptoms in cognitively normal older adults","volume":"175","author":"Donovan","year":"2018","journal-title":"Am J Psychiatry"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/gps.v19:12","article-title":"Prevalence of major and minor depression in elderly persons with mild cognitive impairment\u2013MADRS factor analysis","volume":"19","author":"Gabryelewicz","year":"2004","journal-title":"Int J Geriatr Psychiatry"},{"key":"B18","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/JGP.0b013e3181b0fa13","article-title":"Late-life depression, mild cognitive impairment, and dementia: possible continuum","volume":"18","author":"Panza","year":"2010","journal-title":"Am J Geriatr Psychiatry"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2011.05.2410","article-title":"Neuropsychiatric symptoms in Alzheimer\u2019s disease","volume":"7","author":"Lyketsos","year":"2011","journal-title":"Alzheimers Dement"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/gps.v33.1","article-title":"The impact of anxiety on the progression of mild cognitive impairment to dementia in Chinese and English data bases: a systematic review and meta-analysis","volume":"33","author":"Li","year":"2018","journal-title":"Int J Geriatr Psychiatry"},{"key":"B21","doi-asserted-by":"publisher","first-page":"6555","DOI":"10.1038\/s41598-019-43076-y","article-title":"Synapse loss and progress of Alzheimer\u2019s disease -A network model","volume":"9","author":"Kashyap","year":"2019","journal-title":"Sci Rep"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/cells11162603","article-title":"Cognitive decline and BPSD are concomitant with autophagic and synaptic deficits associated with G9a alterations in aged SAMP8 mice","volume":"11","author":"Vasilopoulou","year":"2022","journal-title":"Cells"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.b.v119b:1","article-title":"Depression in Alzheimer\u2019s disease: the effect of serotonin receptor gene variation","author":"Holmes","year":"2003","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"B24","doi-asserted-by":"publisher","first-page":"5320135","DOI":"10.1155\/2017\/5320135","article-title":"The association between 5HT2A T102C and behavioral and psychological symptoms of dementia in alzheimer\u2019s disease: A meta-analysis","volume":"2017","author":"Tang","year":"2017","journal-title":"BioMed Res Int"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.01421","article-title":"Kaixinsan, a well-known chinese herbal prescription, for alzheimer\u2019s disease and depression: A preclinical systematic review","volume":"13","author":"Fu","year":"2019","journal-title":"Front Neurosci"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17071149","article-title":"Behavioral abnormality induced by enhanced hypothalamo-pituitary-adrenocortical axis activity under dietary zinc deficiency and its usefulness as a model","volume":"17","author":"Takeda","year":"2016","journal-title":"Int J Mol Sci"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2019.05.013","article-title":"Neuroendocrine abnormalities associated with untreated first episode patients with major depressive disorder and bipolar disorder","volume":"107","author":"Feng","year":"2019","journal-title":"Psychoneuroendocrinology"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3999(02)00429-4","article-title":"Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress","volume":"53","author":"Tsigos","year":"2002","journal-title":"J Psychosom Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2015.02.004","article-title":"Beyond the HPA-axis: The role of the gonadal steroid hormone receptors in modulating stress-related responses in an animal model of PTSD","volume":"25","author":"Fenchel","year":"2015","journal-title":"Eur Neuropsychopharmacol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.67595","article-title":"Hypothalamic-pituitary-adrenal (HPA) axis: unveiling the potential mechanisms involved in stress-induced alzheimer\u2019s disease and depression","volume":"16","author":"P","year":"2024","journal-title":"Cureus"},{"key":"B31","doi-asserted-by":"publisher","first-page":"108247","DOI":"10.1016\/j.envint.2023.108247","article-title":"Heat exposure intervention, anxiety level, and multi-omic profiles: A randomized crossover study","volume":"181","author":"Fang","year":"2023","journal-title":"Environ Int"},{"key":"B32","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1159\/000495521","article-title":"Role of hypothalamic-pituitary-adrenal axis, hypothalamic-pituitary-gonadal axis and insulin signaling in the pathophysiology of alzheimer\u2019s disease","volume":"77","author":"Ahmad","year":"2019","journal-title":"Neuropsychobiology"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13020463","article-title":"Chronic stress and headaches: the role of the HPA axis and autonomic nervous system","volume":"13","author":"Sic","year":"2025","journal-title":"Biomedicines"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X21666230811141557","article-title":"The HPA axis as target for depression","volume":"22","author":"Menke","year":"2024","journal-title":"Curr Neuropharmacol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.00443","article-title":"Pharmacological treatment of anxiety disorders: the role of the HPA axis","volume":"11","author":"Tafet","year":"2020","journal-title":"Front Psychiatry"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-022-09767-0","article-title":"The role of testosterone, the androgen receptor, and hypothalamic-pituitary-gonadal axis in depression in ageing Men","volume":"23","author":"Hauger","year":"2022","journal-title":"Rev Endocr Metab Disord"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1097\/FBP.0b013e328308f1fb","article-title":"Effects of central administration of gonadotropin-releasing hormone agonists and antagonist on elevated plus-maze and social interaction behavior in rats","volume":"19","author":"Umathe","year":"2008","journal-title":"Behav Pharmacol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.npep.2008.04.005","article-title":"Gonadotropin-releasing hormone agonist blocks anxiogenic-like and depressant-like effect of corticotrophin-releasing hormone in mice","volume":"42","author":"Umathe","year":"2008","journal-title":"Neuropeptides"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2005.11.015","article-title":"A single administration of testosterone reduces fear-potentiated startle in humans","volume":"59","author":"Hermans","year":"2006","journal-title":"Biol Psychiatry"},{"key":"B40","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/01.pra.0000358315.88931.fc","article-title":"Testosterone and depression: systematic review and meta-analysis","volume":"15","author":"Zarrouf","year":"2009","journal-title":"J Psychiatr Pract"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1180-10.2010","article-title":"Genetic targeting aromatase in male amyloid precursor protein transgenic mice down-regulates beta-secretase (BACE1) and prevents Alzheimer-like pathology and cognitive impairment","volume":"30","author":"McAllister","year":"2010","journal-title":"J Neurosci"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2006.01.018","article-title":"Gonadotropins: a cohesive gender-based etiology of Alzheimer disease","author":"Webber","year":"2007","journal-title":"Mol Cell Endocrinol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2008.05341.x","article-title":"Androgens regulate neprilysin expression: role in reducing beta-amyloid levels","volume":"105","author":"Yao","year":"2008","journal-title":"J Neurochem"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3390\/ph14030246","article-title":"Behavioral and psychological symptoms in dementia (BPSD) and the use of antipsychotics","volume":"14","author":"Calsolaro","year":"2021","journal-title":"Pharm (Basel)"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231810624","article-title":"New atypical antipsychotics in the treatment of schizophrenia and depression","volume":"23","author":"Orzelska-G\u00f3rka","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21249532","article-title":"Mechanism of action of atypical antipsychotic drugs in mood disorders","volume":"21","author":"Grinchii","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.trci.2017.07.001","article-title":"Neuropsychiatric signs and symptoms of Alzheimer\u2019s disease: New treatment paradigms","volume":"3","author":"Lanct\u00f4t","year":"2017","journal-title":"Alzheimers Dement (N Y)"},{"key":"B48","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/01.JGP.0000200589.01396.6d","article-title":"Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials","volume":"14","author":"Schneider","year":"2006","journal-title":"Am J Geriatr Psychiatry"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2014.3018","article-title":"Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm","volume":"72","author":"Maust","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"B50","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/2050-6511-14-10","article-title":"Inappropriate long-term use of antipsychotic drugs is common among people with dementia living in specialized care units","volume":"14","author":"Gustafsson","year":"2013","journal-title":"BMC Pharmacol Toxicol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-4943(01)00137-6","article-title":"Risperidone in the treatment of behavioral disorders in elderly patients with dementia","volume":"7","author":"Gareri","year":"2001","journal-title":"Arch Gerontol Geriatr Suppl"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-5949.2010.00202.x","article-title":"Medicinal plants and dementia therapy: herbal hopes for brain aging","volume":"17","author":"Perry","year":"2011","journal-title":"CNS Neurosci Ther"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1017\/S1041610217001892","article-title":"Treatment effects of Ginkgo biloba extract EGb 761\u00ae on the spectrum of behavioral and psychological symptoms of dementia: meta-analysis of randomized controlled trials","volume":"30","author":"Savaskan","year":"2018","journal-title":"Int Psychogeriatr"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2008.12.008","article-title":"Effect of yokukansan on the behavioral and psychological symptoms of dementia in elderly patients with Alzheimer\u2019s disease","volume":"33","author":"Monji","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.19945\/j.cnki.issn.1006-3250.2024.03.022","article-title":"Effect of Shenghui Yizhi Decoction combined with Donepezil Hydrochloride on Behavioral and Psychological Symptoms of Patients with mild to Moderate Alzheimer\u2019s disease","volume":"30","author":"Wang","year":"2024","journal-title":"J Basic Chin Med"},{"key":"B56","article-title":"Therapeutic effect of Qifuyin combined with Tongqihuoxue Decoction onelderly patients with vascular dementia due to deficiency of Qi and bloodand its influence on nerve function and cerebral blood flow","volume":"38","author":"Wu Kun","year":"2023","journal-title":"J North Sichuan Med College"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.13457\/j.cnki.jncm.2021.14.012","article-title":"Clinical study on modified qifu yin for mild-to-moderate vascularDementia with syndrome of kidney deficiency and marrow depletion","volume":"53","author":"Wang","year":"2021","journal-title":"New Chin Med"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-018-0908-0","article-title":"Qi fu yin-a ming dynasty prescription for the treatment of dementia","volume":"55","author":"Ong","year":"2018","journal-title":"Mol Neurobiol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.18632\/aging.205238","article-title":"Qi Fu Yin ameliorates neuroinflammation through inhibiting RAGE and TLR4\/NF-\u03baB pathway in AD model rats","volume":"15","author":"He","year":"2023","journal-title":"Aging (Albany NY)"},{"key":"B60","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3892\/mmr.2023.13129","article-title":"MCPIP1 alleviates depressive\u2212like behaviors in mice by inhibiting the TLR4\/TRAF6\/NF\u2212\u03baB pathway to suppress neuroinflammation","volume":"29","author":"An","year":"2024","journal-title":"Mol Med Rep"},{"key":"B61","doi-asserted-by":"publisher","first-page":"108725","DOI":"10.1016\/j.intimp.2022.108725","article-title":"Allergic rhinitis in BALB\/c mice is associated with behavioral and hippocampus changes and neuroinflammation via the TLR4\/NF-\u03baB signaling pathway","volume":"108","author":"Ebrahim Soltani","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.1048513","article-title":"Effects of Qi-Fu-Yin on aging of APP\/PS1 transgenic mice by regulating the intestinal microbiome","volume":"12","author":"Xiao","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1183764","article-title":"Qi-fu-yin attenuated cognitive disorders in 5xFAD mice of Alzheimer\u2019s disease animal model by regulating immunity","volume":"14","author":"Yang","year":"2023","journal-title":"Front Neurol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2006.07.007","article-title":"Modeling behavioral and neuronal symptoms of Alzheimer\u2019s disease in mice: a role for intraneuronal amyloid","volume":"31","author":"Gim\u00e9nez-Llort","year":"2007","journal-title":"Neurosci Biobehav Rev"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer\u2019s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"key":"B66","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12974-022-02400-6","article-title":"Edaravone ameliorates depressive and anxiety-like behaviors via Sirt1\/Nrf2\/HO-1\/Gpx4 pathway","volume":"19","author":"Dang","year":"2022","journal-title":"J Neuroinflammation"},{"key":"B67","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0014-2999(03)01272-X","article-title":"The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review","volume":"463","author":"Prut","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2021.05.005","article-title":"Anxiety and Alzheimer\u2019s disease: Behavioral analysis and neural basis in rodent models of Alzheimer\u2019s-related neuropathology","volume":"127","author":"Pentkowski","year":"2021","journal-title":"Neurosci Biobehav Rev"},{"key":"B69","doi-asserted-by":"publisher","first-page":"115859","DOI":"10.1016\/j.biopha.2023.115859","article-title":"Regulation of anxiety-like behaviors by S-palmitoylation and S-nitrosylation in basolateral amygdala","volume":"169","author":"Shen","year":"2023","journal-title":"BioMed Pharmacother"},{"key":"B70","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.neubiorev.2021.06.014","article-title":"The forced swim test: Historical, conceptual and methodological considerations and its relationship with individual behavioral traits","volume":"128","author":"Armario","year":"2021","journal-title":"Neurosci Biobehav Rev"},{"key":"B71","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12974-022-02478-y","article-title":"Asperosaponin VI ameliorates the CMS-induced depressive-like behaviors by inducing a neuroprotective microglial phenotype in hippocampus via PPAR-\u03b3 pathway","volume":"19","author":"Jiang","year":"2022","journal-title":"J Neuroinflammation"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1007\/BF00176475","article-title":"Lack of relationship between effect of desipramine on forced swimming test and brain levels of desipramine or its demethylated metabolite in rats","volume":"92","author":"Mancinelli","year":"1987","journal-title":"Psychopharmacol (Berl)"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2023.04.044","article-title":"Selective aryl hydrocarbon receptor modulators can act as antidepressants in obese female mice","volume":"333","author":"Debler","year":"2023","journal-title":"J Affect Disord"},{"key":"B74","doi-asserted-by":"publisher","first-page":"e10404","DOI":"10.1371\/journal.pone.0010404","article-title":"Association between repeated unpredictable chronic mild stress (UCMS) procedures with a high fat diet: a model of fluoxetine resistance in mice","volume":"5","author":"Isingrini","year":"2010","journal-title":"PloS One"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12050475","article-title":"Amelioration of BPSD-like phenotype and cognitive decline in SAMP8 mice model accompanied by molecular changes after treatment with I(2)-imidazoline receptor ligand MCR5","volume":"12","author":"Vasilopoulou","year":"2020","journal-title":"Pharmaceutics"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jphs.2021.02.006","article-title":"T-type Ca(2+) channel enhancer SAK3 administration improves the BPSD-like behaviors in App(NL-G-F\/NL-G-F) knock-in mice","volume":"146","author":"Degawa","year":"2021","journal-title":"J Pharmacol Sci"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2014.00162","article-title":"Cotinine halts the advance of Alzheimer\u2019s disease-like pathology and associated depressive-like behavior in Tg6799 mice","volume":"6","author":"Patel","year":"2014","journal-title":"Front Aging Neurosci"},{"key":"B78","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.brainres.2017.12.028","article-title":"The locus coeruleus neuroprotective drug vindeburnol normalizes behavior in the 5xFAD transgenic mouse model of Alzheimer\u2019s disease","volume":"1702","author":"Braun","year":"2019","journal-title":"Brain Res"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1002\/cne.v529.7","article-title":"Remodeling of projections from ventral hippocampus to prefrontal cortex in Alzheimer\u2019s mice","volume":"529","author":"Xu","year":"2021","journal-title":"J Comp Neurol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.neures.2022.01.003","article-title":"The effect of exercise on early sensorimotor performance alterations in the 3xTg-AD model of Alzheimer\u2019s disease","volume":"178","author":"Bareiss","year":"2022","journal-title":"Neurosci Res"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01044","article-title":"Effects of the novel IDO inhibitor DWG-1036 on the behavior of male and female 3xTg-AD mice","volume":"10","author":"Fertan","year":"2019","journal-title":"Front Pharmacol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"23739","DOI":"10.18632\/aging.203646","article-title":"Loganin substantially ameliorates molecular deficits, pathologies and cognitive impairment in a mouse model of Alzheimer\u2019s disease","volume":"13","author":"Nie","year":"2021","journal-title":"Aging (Albany NY)."},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.973068","article-title":"The role of PKC\/PKR in aging, Alzheimer\u2019s disease, and perioperative neurocognitive disorders","volume":"14","author":"Lu","year":"2022","journal-title":"Front Aging Neurosci."},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyu020","article-title":"Depressive-like behavior is paired to monoaminergic alteration in a murine model of Alzheimer\u2019s disease","volume":"18","author":"Romano","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1159\/000156475","article-title":"Gender-specific neuroimmunoendocrine aging in a triple-transgenic 3xTg-AD mouse model for Alzheimer\u2019s disease and its relation with longevity","volume":"15","author":"Gim\u00e9nez-Llort","year":"2008","journal-title":"Neuroimmunomodulation"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9070715","article-title":"Genotype load modulates amyloid burden and anxiety-like patterns in male 3xTg-AD survivors despite similar neuro-immunoendocrine, synaptic and cognitive impairments","volume":"9","author":"Muntsant","year":"2021","journal-title":"Biomedicines"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-2012-121438","article-title":"3xTg-AD mice exhibit an activated central stress axis during early-stage pathology","volume":"33","author":"Hebda-Bauer","year":"2013","journal-title":"J Alzheimer\u2019s Dis: JAD"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1002\/j.2040-4603.2016.tb00694.x","article-title":"Regulation of the hypothalamic-pituitary-adrenocortical stress response","volume":"6","author":"Herman","year":"2016","journal-title":"Compr Physiol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1210\/endo-105-3-812","article-title":"Temporal changes in plasma adrenocorticotropin concentration after repeated neurotropic stress in male and female rats","volume":"105","author":"Le Mevel","year":"1979","journal-title":"Endocrinology"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2010.08.068","article-title":"Testosterone regulation of Alzheimer-like neuropathology in male 3xTg-AD mice involves both estrogen and androgen pathways","volume":"1359","author":"Rosario","year":"2010","journal-title":"Brain Res"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2514-06.2006","article-title":"Androgens regulate the development of neuropathology in a triple transgenic mouse model of Alzheimer\u2019s disease","volume":"26","author":"Rosario","year":"2006","journal-title":"J Neurosci"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8529(05)70206-1","article-title":"Neuroendocrine aging in men. Andropause and somatopause","volume":"30","author":"Anawalt","year":"2001","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B93","doi-asserted-by":"publisher","first-page":"111302","DOI":"10.1016\/j.mce.2021.111302","article-title":"The KiNG of reproduction: Kisspeptin\/nNOS interactions shaping hypothalamic GnRH release","volume":"532","author":"Delli","year":"2021","journal-title":"Mol Cell Endocrinol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1216584","article-title":"The value of LH maximum level in predicting optimal oocyte yield following GnRH agonist trigger","volume":"14","author":"Lee","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.982297","article-title":"Novel pituitary actions of GnRH in teleost: The link between reproduction and feeding regulation","volume":"13","author":"Li","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B96","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1176\/appi.ajp.2020.19080848","article-title":"Hormonal treatments for major depressive disorder: state of the art","volume":"177","author":"Dwyer","year":"2020","journal-title":"Am J Psychiatry"},{"key":"B97","doi-asserted-by":"publisher","first-page":"118497","DOI":"10.1016\/j.jep.2024.118497","article-title":"Qifu-yin activates the Keap1\/Nrf2\/ARE signaling and ameliorates synaptic injury and oxidative stress in APP\/PS1 mice","volume":"333","author":"Wang","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/S1875-5364(14)60135-7","article-title":"Qifu-Yin attenuates AGEs-induced Alzheimer-like pathophysiological changes through the RAGE\/NF-\u03baB pathway","volume":"12","author":"Wang","year":"2014","journal-title":"Chin J Nat Med"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2025.1554866\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T05:40:26Z","timestamp":1747201226000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2025.1554866\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,14]]},"references-count":98,"alternative-id":["10.3389\/fpsyt.2025.1554866"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2025.1554866","relation":{},"ISSN":["1664-0640"],"issn-type":[{"type":"electronic","value":"1664-0640"}],"subject":[],"published":{"date-parts":[[2025,5,14]]},"article-number":"1554866"}}